Letters
Authors' reply
BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7026.312c (Published 03 February 1996) Cite this as: BMJ 1996;312:312
- M Brautigam,
- G Weidinger,
- S Nolting,
- R E Schopf
- Head of dermatology Head of clinical research Sandoz AG, 90429 Nuremberg, Germany
- Professor of dermatology and allergy University of Munster, Munster, Germany
- Professor of dermatology University of Mainz, 55131 Mainz, Germany
EDITOR,—David S Buck suggests that in some patients one year may be too short for a final assessment of therapeutic efficacy in toenail tinea infection. We agree that our figure and the numerical data suggest a plateauing or even slight decrease in the length of unaffected nail in the itraconazole group. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.